Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stoffers, D. A.
Right arrow Articles by Egan, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stoffers, D. A.
Right arrow Articles by Egan, J. M.
Social Bookmarking
Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes, Vol 49, Issue 5 741-748, Copyright © 2000 by American Diabetes Association

ARTICLES

Insulinotropic glucagon-like peptide 1 agonists stimulate expression of homeodomain protein IDX-1 and increase islet size in mouse pancreas

DA Stoffers, TJ Kieffer, MA Hussain, DJ Drucker, S Bonner-Weir, JF Habener and JM Egan
Division of Endocrinology, Diabetes and Metabolism, University of Pennsylvania School of Medicine, Philadelphia, USA.

Diabetes is caused by a failure of the pancreas to produce insulin in amounts sufficient to meet the body's needs. A hallmark of diabetes is an absolute (type 1) or relative (type 2) reduction in the mass of pancreatic beta-cells that produce insulin. Mature beta-cells have a lifespan of approximately 48-56 days (rat) and are replaced by the replication of preexisting beta-cells and by the differentiation and proliferation of new beta-cells (neogenesis) derived from the pancreatic ducts. Here, we show that the insulinotropic hormone glucagon-like peptide (GLP)-1, which is produced by the intestine, enhances the pancreatic expression of the homeodomain transcription factor IDX-1 that is critical for pancreas development and the transcriptional regulation of the insulin gene. Concomitantly, GLP-1 administered to diabetic mice stimulates insulin secretion and effectively lowers their blood sugar levels. GLP-1 also enhances beta-cell neogenesis and islet size. Thus, in addition to stimulating insulin secretion, GLP-1 stimulates the expression of the transcription factor IDX-1 while stimulating beta-cell neogenesis and may thereby be an effective treatment for diabetes.
Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 DiabetesHome page
W.-J. Song, W. E. Schreiber, E. Zhong, F.-F. Liu, B. D. Kornfeld, F. E. Wondisford, and M. A. Hussain
Exendin-4 Stimulation of Cyclin A2 in {beta}-Cell Proliferation
Diabetes, September 1, 2008; 57(9): 2371 - 2381.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
S. Klinger, C. Poussin, M.-B. Debril, W. Dolci, P. A. Halban, and B. Thorens
Increasing GLP-1-Induced {beta}-Cell Proliferation by Silencing the Negative Regulators of Signaling cAMP Response Element Modulator-{alpha} and DUSP14
Diabetes, March 1, 2008; 57(3): 584 - 593.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
V. Koya, S. Lu, Y.-P. Sun, D. L. Purich, M. A. Atkinson, S.-W. Li, and L.-J. Yang
Reversal of Streptozotocin-Induced Diabetes in Mice by Cellular Transduction With Recombinant Pancreatic Transcription Factor Pancreatic Duodenal Homeobox-1: A Novel Protein Transduction Domain-Based Therapy
Diabetes, March 1, 2008; 57(3): 757 - 769.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
B. J. Lamont and D. J. Drucker
Differential Antidiabetic Efficacy of Incretin Agonists Versus DPP-4 Inhibition in High Fat Fed Mice
Diabetes, January 1, 2008; 57(1): 190 - 198.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
D. M. Keller, S. McWeeney, A. Arsenlis, J. Drouin, C. V. E. Wright, H. Wang, C. B. Wollheim, P. White, K. H. Kaestner, and R. H. Goodman
Characterization of Pancreatic Transcription Factor Pdx-1 Binding Sites Using Promoter Microarray and Serial Analysis of Chromatin Occupancy
J. Biol. Chem., November 2, 2007; 282(44): 32084 - 32092.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
N. A. Sherry, W. Chen, J. A. Kushner, M. Glandt, Q. Tang, S. Tsai, P. Santamaria, J. A. Bluestone, A.-M. B. Brillantes, and K. C. Herold
Exendin-4 Improves Reversal of Diabetes in NOD Mice Treated with Anti-CD3 Monoclonal Antibody by Enhancing Recovery of {beta}-Cells
Endocrinology, November 1, 2007; 148(11): 5136 - 5144.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. Rev.Home page
J. J. Holst
The Physiology of Glucagon-like Peptide 1
Physiol Rev, October 1, 2007; 87(4): 1409 - 1439.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
B. L. Wajchenberg
{beta}-Cell Failure in Diabetes and Preservation by Clinical Treatment
Endocr. Rev., April 1, 2007; 28(2): 187 - 218.
[Abstract] [Full Text] [PDF]

Home page
 J EndocrinolHome page
T. H Claus, C. Q Pan, J. M Buxton, L. Yang, J. C Reynolds, N. Barucci, M. Burns, A. A Ortiz, S. Roczniak, J. N Livingston, et al.
Dual-acting peptide with prolonged glucagon-like peptide-1 receptor agonist and glucagon receptor antagonist activity for the treatment of type 2 diabetes
J. Endocrinol., February 1, 2007; 192(2): 371 - 380.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
D. Chen, J. Liao, N. Li, C. Zhou, Q. Liu, G. Wang, R. Zhang, S. Zhang, L. Lin, K. Chen, et al.
From the Cover: A nonpeptidic agonist of glucagon-like peptide 1 receptors with efficacy in diabetic db/db mice
PNAS, January 16, 2007; 104(3): 943 - 948.
[Abstract] [Full Text] [PDF]

Home page
 The Annals of PharmacotherapyHome page
R K. Campbell
Rationale for Dipeptidyl Peptidase 4 Inhibitors: A New Class of Oral Agents for the Treatment of Type 2 Diabetes Mellitus
Ann. Pharmacother., January 1, 2007; 41(1): 51 - 60.
[Abstract] [Full Text] [PDF]

Home page
 Eur J EndocrinolHome page
M. E Cerf
Transcription factors regulating {beta}-cell function.
Eur. J. Endocrinol., November 1, 2006; 155(5): 671 - 679.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
M. A. Hussain, D. L. Porras, M. H. Rowe, J. R. West, W.-J. Song, W. E. Schreiber, and F. E. Wondisford
Increased Pancreatic {beta}-Cell Proliferation Mediated by CREB Binding Protein Gene Activation
Mol. Cell. Biol., October 15, 2006; 26(20): 7747 - 7759.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
L.-X. Li, P. E. MacDonald, D. S. Ahn, G. Y. Oudit, P. H. Backx, and P. L. Brubaker
Role of Phosphatidylinositol 3-Kinase{gamma} in the {beta}-Cell: Interactions with Glucagon-Like Peptide-1
Endocrinology, July 1, 2006; 147(7): 3318 - 3325.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
J. Mu, J. Woods, Y.-P. Zhou, R. S. Roy, Z. Li, E. Zycband, Y. Feng, L. Zhu, C. Li, A. D. Howard, et al.
Chronic Inhibition of Dipeptidyl Peptidase-4 With a Sitagliptin Analog Preserves Pancreatic {beta}-Cell Mass and Function in a Rodent Model of Type 2 Diabetes
Diabetes, June 1, 2006; 55(6): 1695 - 1704.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
J. Buteau, M. L. Spatz, and D. Accili
Transcription Factor FoxO1 Mediates Glucagon-Like Peptide-1 Effects on Pancreatic {beta}-Cell Mass.
Diabetes, May 1, 2006; 55(5): 1190 - 1196.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
J. A. Koehler and D. J. Drucker
Activation of glucagon-like Peptide-1 receptor signaling does not modify the growth or apoptosis of human pancreatic cancer cells.
Diabetes, May 1, 2006; 55(5): 1369 - 1379.
[Abstract] [Full Text] [PDF]

Home page
 Annals of Clinical & Laboratory ScienceHome page
Y. Lu, Z. Wang, and M. Zhu
Human bone marrow mesenchymal stem cells transfected with human insulin genes can secrete insulin stably.
Ann. Clin. Lab. Sci., March 1, 2006; 36(2): 127 - 136.
[Abstract] [Full Text] [PDF]

Home page
 J EndocrinolHome page
B. N Friedrichsen, N. Neubauer, Y. C Lee, V. K Gram, N. Blume, J. S Petersen, J. H Nielsen, and A. Moldrup
Stimulation of pancreatic {beta}-cell replication by incretins involves transcriptional induction of cyclin D1 via multiple signalling pathways.
J. Endocrinol., March 1, 2006; 188(3): 481 - 492.
[Abstract] [Full Text] [PDF]

Home page
 PhysiologyHome page
S. P. Raikwar, T. Mueller, and N. Zavazava
Strategies for Developing Therapeutic Application of Human Embryonic Stem Cells
Physiology, February 1, 2006; 21(1): 19 - 28.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
C. S. Lee, D. D. De Leon, K. H. Kaestner, and D. A. Stoffers
Regeneration of Pancreatic Islets After Partial Pancreatectomy in Mice Does Not Involve the Reactivation of Neurogenin-3
Diabetes, February 1, 2006; 55(2): 269 - 272.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. GenomicsHome page
D. D. De Leon, C. Farzad, M. F. Crutchlow, J. Brestelli, J. Tobias, K. H. Kaestner, and D. A. Stoffers
Identification of transcriptional targets during pancreatic growth after partial pancreatectomy and exendin-4 treatment
Physiol Genomics, January 12, 2006; 24(2): 133 - 143.
[Abstract] [Full Text] [PDF]

Home page
 J EndocrinolHome page
L Bai, G Meredith, and B E Tuch
Glucagon-like peptide-1 enhances production of insulin in insulin-producing cells derived from mouse embryonic stem cells
J. Endocrinol., August 1, 2005; 186(2): 343 - 352.
[Abstract] [Full Text] [PDF]

Home page
 J EndocrinolHome page
C. W Hay, E. M Sinclair, G. Bermano, E. Durward, M. Tadayyon, and K. Docherty
Glucagon-like peptide-1 stimulates human insulin promoter activity in part through cAMP-responsive elements that lie upstream and downstream of the transcription start site
J. Endocrinol., August 1, 2005; 186(2): 353 - 365.
[Abstract] [Full Text] [PDF]

Home page
 Clin. DiabetesHome page
K. Dungan and J. B. Buse
Glucagon-Like Peptide 1-Based Therapies for Type 2 Diabetes: A Focus on Exenatide
Clin. Diabetes, April 1, 2005; 23(2): 56 - 62.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
B. R. Gedulin, S. E. Nikoulina, P. A. Smith, G. Gedulin, L. L. Nielsen, A. D. Baron, D. G. Parkes, and A. A. Young
Exenatide (Exendin-4) Improves Insulin Sensitivity and {beta}-Cell Mass in Insulin-Resistant Obese fa/fa Zucker Rats Independent of Glycemia and Body Weight
Endocrinology, April 1, 2005; 146(4): 2069 - 2076.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
M. Brissova, M. Blaha, C. Spear, W. Nicholson, A. Radhika, M. Shiota, M. J. Charron, C. V. E. Wright, and A. C. Powers
Reduced PDX-1 expression impairs islet response to insulin resistance and worsens glucose homeostasis
Am J Physiol Endocrinol Metab, April 1, 2005; 288(4): E707 - E714.
[Abstract] [Full Text] [PDF]

Home page
 Sci SignalHome page
G. G. Holz and O. G. Chepurny
Diabetes Outfoxed by GLP-1?
Sci. Signal., January 25, 2005; 2005(268): pe2 - pe2.
[Abstract] [Full Text] [PDF]

Home page
 J EndocrinolHome page
H Del Zotto, M I Borelli, L Flores, M E Garcia, C L Gomez Dumm, A Chicco, Y B Lombardo, and J J Gagliardino
Islet neogenesis: an apparent key component of long-term pancreas adaptation to increased insulin demand
J. Endocrinol., November 1, 2004; 183(2): 321 - 330.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
K.-H. Yew, K. L. Prasadan, B. L. Preuett, M. J. Hembree, C. R. McFall, C. L. Benjes, A. R. Crowley, S. L. Sharp, Z. Li, S. S. Tulachan, et al.
Interplay of Glucagon-Like Peptide-1 and Transforming Growth Factor-{beta} Signaling in Insulin-Positive Differentiation of AR42J Cells
Diabetes, November 1, 2004; 53(11): 2824 - 2835.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
C. F. Deacon
Therapeutic Strategies Based on Glucagon-Like Peptide 1
Diabetes, September 1, 2004; 53(9): 2181 - 2189.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
J. J. Holst and J. Gromada
Role of incretin hormones in the regulation of insulin secretion in diabetic and nondiabetic humans
Am J Physiol Endocrinol Metab, August 1, 2004; 287(2): E199 - E206.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
N. Ogawa, J. F. List, J. F. Habener, and T. Maki
Cure of Overt Diabetes in NOD Mice by Transient Treatment With Anti-Lymphocyte Serum and Exendin-4
Diabetes, July 1, 2004; 53(7): 1700 - 1705.
[Abstract] [Full Text] [PDF]

Home page
 JRSMHome page
C M. B Edwards
GLP-1: target for a new class of antidiabetic agents?
J R Soc Med, June 1, 2004; 97(6): 270 - 274.
[Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
J. F. List and J. F. Habener
Glucagon-like peptide 1 agonists and the development and growth of pancreatic {beta}-cells
Am J Physiol Endocrinol Metab, June 1, 2004; 286(6): E875 - E881.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
D. A. D'Alessio and T. P. Vahl
Glucagon-like peptide 1: evolution of an incretin into a treatment for diabetes
Am J Physiol Endocrinol Metab, June 1, 2004; 286(6): E882 - E890.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
P. L. Brubaker and D. J. Drucker
Minireview: Glucagon-Like Peptides Regulate Cell Proliferation and Apoptosis in the Pancreas, Gut, and Central Nervous System
Endocrinology, June 1, 2004; 145(6): 2653 - 2659.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
K. B. Degn, C. B. Juhl, J. Sturis, G. Jakobsen, B. Brock, V. Chandramouli, J. Rungby, B. R. Landau, and O. Schmitz
One Week's Treatment With the Long-Acting Glucagon-Like Peptide 1 Derivative Liraglutide (NN2211) Markedly Improves 24-h Glycemia and {alpha}- and {beta}-Cell Function and Reduces Endogenous Glucose Release in Patients with Type 2 Diabetes
Diabetes, May 1, 2004; 53(5): 1187 - 1194.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
I. Cozar-Castellano, K. K. Takane, R. Bottino, A.N. Balamurugan, and A. F. Stewart
Induction of {beta}-Cell Proliferation and Retinoblastoma Protein Phosphorylation in Rat and Human Islets Using Adenovirus-Mediated Transfer of Cyclin-Dependent Kinase-4 and Cyclin D1
Diabetes, January 1, 2004; 53(1): 149 - 159.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
J. A. Ehses, V. R. Casilla, T. Doty, J. A. Pospisilik, K. D. Winter, H.-U. Demuth, R. A. Pederson, and C. H. S. McIntosh
Glucose-Dependent Insulinotropic Polypeptide Promotes {beta}-(INS-1) Cell Survival via Cyclic Adenosine Monophosphate-Mediated Caspase-3 Inhibition and Regulation of p38 Mitogen-Activated Protein Kinase
Endocrinology, October 1, 2003; 144(10): 4433 - 4445.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
T. Bock, B. Pakkenberg, and K. Buschard
Increased Islet Volume but Unchanged Islet Number in ob/ob Mice
Diabetes, July 1, 2003; 52(7): 1716 - 1722.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
Y. Anini and P. L. Brubaker
Muscarinic Receptors Control Glucagon-Like Peptide 1 Secretion by Human Endocrine L Cells
Endocrinology, July 1, 2003; 144(7): 3244 - 3250.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
J. M. Egan, G. S. Meneilly, and D. Elahi
Effects of 1-mo bolus subcutaneous administration of exendin-4 in type 2 diabetes
Am J Physiol Endocrinol Metab, June 1, 2003; 284(6): E1072 - E1079.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
D. A. Stoffers, B. M. Desai, D. D. DeLeon, and R. A. Simmons
Neonatal Exendin-4 Prevents the Development of Diabetes in the Intrauterine Growth Retarded Rat
Diabetes, March 1, 2003; 52(3): 734 - 740.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
J. A. Pospisilik, J. Martin, T. Doty, J. A. Ehses, N. Pamir, F. C. Lynn, S. Piteau, H.-U. Demuth, C. H.S. McIntosh, and R. A. Pederson
Dipeptidyl Peptidase IV Inhibitor Treatment Stimulates {beta}-Cell Survival and Islet Neogenesis in Streptozotocin-Induced Diabetic Rats
Diabetes, March 1, 2003; 52(3): 741 - 750.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
J.-G. Kim, L. L. Baggio, D. P. Bridon, J.-P. Castaigne, M. F. Robitaille, L. Jette, C. Benquet, and D. J. Drucker
Development and Characterization of a Glucagon-Like Peptide 1-Albumin Conjugate: The Ability to Activate the Glucagon-Like Peptide 1 Receptor In Vivo
Diabetes, March 1, 2003; 52(3): 751 - 759.
[Abstract] [Full Text] [PDF]

Home page
 Pharmacol. Rev.Home page
M. E. Doyle and J. M. Egan
Pharmacological Agents That Directly Modulate Insulin Secretion
Pharmacol. Rev., March 1, 2003; 55(1): 105 - 131.
[Abstract] [Full Text] [PDF]

Home page
 Pharmacol. Rev.Home page
K. E. Mayo, L. J. Miller, D. Bataille, S. Dalle, B. Goke, B. Thorens, and D. J. Drucker
International Union of Pharmacology. XXXV. The Glucagon Receptor Family
Pharmacol. Rev., March 1, 2003; 55(1): 167 - 194.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
R. N. Re
Implications of intracrine hormone action for physiology and medicine
Am J Physiol Heart Circ Physiol, March 1, 2003; 284(3): H751 - H757.
[Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
D. J. Drucker
Glucagon-Like Peptides: Regulators of Cell Proliferation, Differentiation, and Apoptosis
Mol. Endocrinol., February 1, 2003; 17(2): 161 - 171.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
Y. Anini and P. L. Brubaker
Role of Leptin in the Regulation of Glucagon-Like Peptide-1 Secretion
Diabetes, February 1, 2003; 52(2): 252 - 259.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
D. D. De Leon, S. Deng, R. Madani, R. S. Ahima, D. J. Drucker, and D. A. Stoffers
Role of Endogenous Glucagon-Like Peptide-1 in Islet Regeneration After Partial Pancreatectomy
Diabetes, February 1, 2003; 52(2): 365 - 371.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
D. K.Y. Trinh, K. Zhang, M. Hossain, P. L. Brubaker, and D. J. Drucker
Pax-6 Activates Endogenous Proglucagon Gene Expression in the Rodent Gastrointestinal Epithelium
Diabetes, February 1, 2003; 52(2): 425 - 433.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
Y. Li, T. Hansotia, B. Yusta, F. Ris, P. A. Halban, and D. J. Drucker
Glucagon-like Peptide-1 Receptor Signaling Modulates beta Cell Apoptosis
J. Biol. Chem., January 3, 2003; 278(1): 471 - 478.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
L. Rachdi, J.-C. Marie, and R. Scharfmann
Role for VPAC2 Receptor-Mediated Signals in Pancreas Development
Diabetes, January 1, 2003; 52(1): 85 - 92.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
J. Buteau, S. Foisy, E. Joly, and M. Prentki
Glucagon-Like Peptide 1 Induces Pancreatic {beta}-Cell Proliferation Via Transactivation of the Epidermal Growth Factor Receptor
Diabetes, January 1, 2003; 52(1): 124 - 132.
[Abstract] [Full Text] [PDF]